Kristen Krysko, MD, suggests that modern fertility treatments and appropriately timed disease-modifying therapies may not ...
Patients with multiple sclerosis receiving chronic ocrelizumab treatment may develop hypogammaglobulinemia and experience ...
The absolute number of multiple sclerosis deaths in the United States increased significantly between 1999 and 2020.
Tocilizumab may offer more consistent relapse suppression than rituximab in MOGAD, though pooled estimates do not establish ...
Valerie Block, PT, DPTSc, discusses the potential role of wearable devices for tracking daily symptom variability in patients with multiple sclerosis. Interview Transcript Valerie Block, PT, DPTSc: Hi ...
Stijn Denissen, PhD: I’m Stijn. I’m actually from the Netherlands. I live in Belgium, so I found my love here. Also, for medicine and the AI intersection, many of those things happened here in Belgium ...
High baseline fatigue and depression scores can predict a persistently high fatigue burden over time in secondary progressive ...
Among women with multiple sclerosis receiving ofatumumab, postmenopausal status is linked to higher disability scores and ...
Researchers evaluated disease activity, disability progression, and treatment patterns across multiple sclerosis phenotypes. Disability progression in multiple sclerosis was common despite treatment ...
The Food and Drug Administration (FDA) has granted Fast Track designation to AV-1959R for the prevention of Alzheimer disease in cognitively unimpaired individuals with biomarker evidence of amyloid ...
Women with endometriosis have more than twice the odds of migraine, but short-term billing records may substantially underestimate the overlap.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results